The Affymetrix U133 Plug 2.0 gene chip data indicated that the levels of the G6PD signal in the relapsed MM patients were significantly higher than the baseline, and G6PD expression was positively correlated with a worse outcome compared with the healthy individuals (Fig. 4a, b). Here, G6PD is linked to Miyoshi myopathy.